Clinical research involving transcutaneous electrical nerve stimulation (TENS) devices has concluded in its application for pain management during fusion-guided prostate biopsy procedures. This Medical University of Gdansk study offers insights that could influence clinical practice and regulatory decision-making.
In this article:
- What changed?
- How was the device evaluated?
- What is the intended use of these devices?
- FAQ
- Conclusion
- Disclaimer
- Full study details
What changed?
This completed clinical trial, registered under the identifier NCT07331246, assessed the efficacy of TENS devices versus sham TENS devices during prostate cancer diagnostics. Conducted by the Medical University of Gdansk, it focused on patients undergoing fusion-guided prostate biopsy. The final results could help refine pain management strategies during invasive diagnostic procedures.
How was the device evaluated?
This study directly compared three intervention arms:
- Active TENS devices: Using transcutaneous electrical nerve stimulation intended to alleviate pain.
- Sham TENS devices: Inactive control devices designed to measure placebo effects.
- Local anesthesia: Included for additional comparison with traditional pain relief methods.
The investigators monitored pain levels experienced during the biopsy procedure to assess the efficacy of these devices. Regulatory teams may note this as crucial for understanding how active versus sham treatments influence patient outcomes.
What is the intended use of these devices?
TENS is a non-invasive device aimed at managing procedural pain by delivering controlled electrical impulses to targeted areas of the body. In this trial, its application during prostate biopsies highlights its function in specific diagnostic environments. Understanding its intended purpose and objectively verifying performance are necessary steps toward regulatory compliance, particularly under MDR Annex XIV standards.
FAQ
1. What devices were studied?
The trial assessed active and sham TENS devices against local anesthesia for managing procedure-related pain.
2. Who sponsored the research?
The Medical University of Gdansk sponsored this research.
3. What procedures were targeted?
Procedures involved fusion-guided prostate biopsy, a diagnostic method for prostate cancer evaluation.
4. Is the study completed?
Yes, it was completed as of the publication date.
Conclusion
The trial offers important data for healthcare providers, regulatory agencies, and device manufacturers. TENS devices could provide a less invasive approach to pain management in specific diagnostic settings, but further dissemination of findings is needed to influence broader clinical practices.
Disclaimer
This article is for informational purposes only and does not constitute medical, legal, or regulatory advice. Professionals should consult official sources for compliance guidance.
Full study details
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07331246?term=medical+device